Flavoxate

Revision as of 02:45, 9 August 2012 by WikiBot (talk | contribs) (Bot: Automated text replacement (-{{SIB}} + & -{{EJ}} + & -{{EH}} + & -{{Editor Join}} + & -{{Editor Help}} +))
Jump to navigation Jump to search
Flavoxate
Clinical data
ATC code
Identifiers
CAS Number
PubChem CID
DrugBank
E number{{#property:P628}}
ECHA InfoCard{{#property:P2566}}Lua error in Module:EditAtWikidata at line 36: attempt to index field 'wikibase' (a nil value).
Chemical and physical data
FormulaC24H25NO4
Molar mass391.46 g/mol

WikiDoc Resources for Flavoxate

Articles

Most recent articles on Flavoxate

Most cited articles on Flavoxate

Review articles on Flavoxate

Articles on Flavoxate in N Eng J Med, Lancet, BMJ

Media

Powerpoint slides on Flavoxate

Images of Flavoxate

Photos of Flavoxate

Podcasts & MP3s on Flavoxate

Videos on Flavoxate

Evidence Based Medicine

Cochrane Collaboration on Flavoxate

Bandolier on Flavoxate

TRIP on Flavoxate

Clinical Trials

Ongoing Trials on Flavoxate at Clinical Trials.gov

Trial results on Flavoxate

Clinical Trials on Flavoxate at Google

Guidelines / Policies / Govt

US National Guidelines Clearinghouse on Flavoxate

NICE Guidance on Flavoxate

NHS PRODIGY Guidance

FDA on Flavoxate

CDC on Flavoxate

Books

Books on Flavoxate

News

Flavoxate in the news

Be alerted to news on Flavoxate

News trends on Flavoxate

Commentary

Blogs on Flavoxate

Definitions

Definitions of Flavoxate

Patient Resources / Community

Patient resources on Flavoxate

Discussion groups on Flavoxate

Patient Handouts on Flavoxate

Directions to Hospitals Treating Flavoxate

Risk calculators and risk factors for Flavoxate

Healthcare Provider Resources

Symptoms of Flavoxate

Causes & Risk Factors for Flavoxate

Diagnostic studies for Flavoxate

Treatment of Flavoxate

Continuing Medical Education (CME)

CME Programs on Flavoxate

International

Flavoxate en Espanol

Flavoxate en Francais

Business

Flavoxate in the Marketplace

Patents on Flavoxate

Experimental / Informatics

List of terms related to Flavoxate


Flavoxate is an anticholinergic with antimuscarinic effects. Its muscle relaxant properties may be due to a direct action on the smooth muscle rather than by antagonizing muscarinic receptors.

Clinical uses

Flavoxate is used to treat urinary bladder spasms. It is available under the trade name Urispas (Paladin),Uritac by El Saad company in Syria, or under the name Bladderon by Nippon Shinyaku of Japan.

Flavoxate HCl is indicated for symptomatic relief of interstitial cystitis, dysuria, urgency, nocturia, suprapubic pain, frequency and incontinence as may occur in cystitis, prostatitis, urethritis, urethrocystitis/urethrotrigonitis.


Adverse Reactions The following adverse reactions have been observed, but there are not enough data to support an estimate of their frequency. Nausea, vomiting, dry mouth vertigo, headache, mental confusion, especially in the elderly, drowsiness, nervousness. tachycardia and palpitation. urticaria and other dermatoses, eosinophilia and hyperpyrexia, increased ocular tension, blurred vision, disturbance in eye accommodation and dysuria.

Contraindications: Flavoxate HCl is contraindicated in patients who have any of the following obstructive conditions: pyloric or duodenal obstruction, obstructive intestinal lesions or ileus, achalasia, gastrointestinal hemorrhage and obstructive uropathies of the lower urinary tract.

Sources

  • Brenner, G. M. (2000). Pharmacology. Philadelphia, PA: W.B. Saunders Company. ISBN 0-7216-7757-6
  • Canadian Pharmacists Association (2000). Compendium of Pharmaceuticals and Specialties (25th ed.). Toronto, ON: Webcom. ISBN 0-919115-76-4

Template:WH Template:WS